Clinical relevance of ion channels for diagnosis and therapy of cancer.
about
Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau proteinPolymodal roles of transient receptor potential channels in the control of ocular functionOcular transient receptor potential channel function in health and disease.General Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMACInhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas.The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors.Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma.Is there a role for voltage-gated Na+ channels in the aggressiveness of breast cancer?Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.Efficacy of a hypotonic treatment for peritoneal dissemination from gastric cancer cells: an in vivo evaluationA novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells.The K-Cl cotransporter KCC3 as an independent prognostic factor in human esophageal squamous cell carcinoma.Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.Function of chloride intracellular channel 1 in gastric cancer cells.The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.The transition from proliferation to differentiation in colorectal cancer is regulated by the calcium activated chloride channel A1.Altered expression of two-pore domain potassium (K2P) channels in cancerInvolvement of Transient Receptor Potential Melastatin 7 Channels in Sophorae Radix-induced Apoptosis in Cancer Cells: Sophorae Radix and TRPM7.Effects of Ulmi Pumilae Cortex on AGS Gastric Cancer Cells.Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.Overexpression of Eag1 potassium channels in clinical tumours.Evaluation of the efficacy of peritoneal lavage with distilled water in colorectal cancer surgery: in vitro and in vivo study.EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.Regulation of osmolality for cancer treatment.Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model.Genome-wide analysis reveals conserved transcriptional responses downstream of resting potential change in Xenopus embryos, axolotl regeneration, and human mesenchymal cell differentiation.Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and CancerThe overexpressed functional transient receptor potential channel TRPM2 in oral squamous cell carcinoma.Emerging roles of Orai3 in pathophysiology.Potential role of melastatin-related transient receptor potential cation channel subfamily M gene expression in the pathogenesis of urinary bladder cancer.Ion channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis.Mitochondrial ion channels as oncological targets.Cellular physiological approach for treatment of gastric cancer.Intracellular chloride regulates the G(1)/S cell cycle progression in gastric cancer cells.Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis.Sodium ion channel mutations in glioblastoma patients correlate with shorter survival.Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells.Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells.Monovalent ions control proliferation of Ehrlich Lettre ascites cells.The Bioelectric Code: Reprogramming Cancer and Aging From the Interface of Mechanical and Chemical Microenvironments.
P2860
Q24676422-45695096-D09E-4013-BFD1-72E2857A508FQ26775572-DFB74E66-BBF3-4E49-8459-9D701913351CQ27686780-906CAFB2-F900-4121-BA61-0B09381730CFQ28385542-CDF770D8-DA67-4890-B662-C3B1401FD597Q30490414-A0450A04-FC10-46E3-BD72-C5FC38F2F18AQ33685939-C75C7502-0E45-47A3-ABEB-40D9FCB0BE4DQ33735267-108DD648-D5AF-40CB-8C24-83D61D17E3BEQ33777055-C27EF7CD-3EFB-40BD-8E04-F0DFA1E21D6DQ33802553-78EF75F1-49F7-4E3F-93AC-095C8642DB3CQ33908921-97B56B68-653A-40AC-A035-491A750B173AQ33911271-776BE74A-A53C-4894-931F-F12531942E6DQ33992830-425228D5-082F-40C5-8959-D971751E84C3Q34024653-2BFF2305-4EDA-4AA7-AF08-309A42502895Q34335408-E5781169-79D1-4382-8E6D-FBC042885218Q34460616-874391A4-2246-4FA5-92DF-F55FCAD51E6DQ34674274-594819EB-A8CD-412D-8B7E-657AE2480D40Q35014316-1C1B9FF7-E10B-4D7E-B471-B4068F1B9C0CQ35093525-7349B782-6400-47A7-9EC1-5795838D9D82Q35093573-ECBD0DCE-82F5-41E5-988E-065CB4BF1D8DQ35093966-B531D321-FCAB-4462-A02D-A82627E0C0C8Q35107467-CAB90D03-189B-4609-B288-2F91A6BF138DQ35183465-AA6F23C2-F3C4-449A-9098-561F307DAAD6Q36266346-FE301972-7517-4943-AD11-020183845E79Q36276348-D9612CC2-0E61-4D0A-9FA9-75F75499892DQ36790917-61D57DF9-33A9-4379-813C-680F5EACEDAAQ36872719-0AD6980C-344F-4335-9AA7-B449A0EB683CQ37152732-12641D47-D143-4A96-97F7-60DE72A0B43EQ37529072-5B9F3191-B7ED-46EE-A545-BC395FF1E1EBQ37554601-CBFBD0F6-CB34-4626-A233-C35D67DBF465Q37581967-C07BCE77-4AA5-4146-94E1-F5B036BCC8F1Q37937313-948333D6-5B4A-4F90-AF30-4B855CF717E9Q38182357-1274F690-FD27-49D3-8A30-AC034B2A4955Q38247979-4A39736E-7F6B-409B-8AD6-F39988676D49Q38689500-83F86B35-291A-4EA5-9B00-0089E8A72D65Q38704738-999CA432-4F9D-4B03-888A-EACB066B09A1Q39593919-A42EB5BB-E7FB-44EF-A6D0-0BF34FBBE7CFQ40020264-4DF171C0-348F-45CD-9984-10DC418919CFQ42247368-4E9F29E6-75C4-4ADA-A236-5531A0F3B93BQ42997748-98875E88-2FC7-4F49-B226-5800740E7ECDQ51761058-FB90F049-BB93-40F8-B843-6C795A5B8F7A
P2860
Clinical relevance of ion channels for diagnosis and therapy of cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Clinical relevance of ion channels for diagnosis and therapy of cancer.
@ast
Clinical relevance of ion channels for diagnosis and therapy of cancer.
@en
type
label
Clinical relevance of ion channels for diagnosis and therapy of cancer.
@ast
Clinical relevance of ion channels for diagnosis and therapy of cancer.
@en
prefLabel
Clinical relevance of ion channels for diagnosis and therapy of cancer.
@ast
Clinical relevance of ion channels for diagnosis and therapy of cancer.
@en
P1476
Clinical relevance of ion channels for diagnosis and therapy of cancer.
@en
P2093
Schönherr R
P2888
P304
P356
10.1007/S00232-005-0782-3
P577
2005-06-01T00:00:00Z